35
Participants
Start Date
October 31, 2000
Primary Completion Date
May 31, 2013
Study Completion Date
June 30, 2013
Anastrozole (Arimidex)
Anastrozole is a prescription hormonal treatment that helps fight breast cancer by lowering the amount of estrogen in the body. It is a non-steroidal aromatase inhibitor, which significantly lowers serum estradiol (estrogen) concentrations, without interfering with the formation of adrenal corticosteroids or aldosterone
Goserelin (Zoladex)
Goserelin is a palliative treatment of advanced breast cancer in pre- and perimenopausal women
Stanford University School of Medicine, Stanford
Collaborators (1)
AstraZeneca
INDUSTRY
Stanford University
OTHER